Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Patient enrollment completed for phase III clinical trial with Tarceva

Aug. 7, 2002

Potential role for CEP-701 in the treatment of acute myeloid leukemia

Aug. 7, 2002

Novel topoisomerase I inhibitors in Advanced Life Sciences pipeline

Aug. 6, 2002

MTC-DOX designated orphan drug in E.U.

Aug. 6, 2002

Xyotax enters phase II trial in breast cancer

Aug. 6, 2002

Antitumor compound from natural source identified at Pharma Mar

Aug. 5, 2002

New CDK inhibitors emerge from Pharmacia R&D

Aug. 5, 2002

New data on the antitumor effects of the monoclonal antibody IMC-C225

Aug. 5, 2002

P&G scientists describe novel benzimidazole with antitumor/antiviral activity

Aug. 2, 2002

Androgen suppression improves outcomes in the radiotherapy of locally advanced prostate cancer

Aug. 2, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...